• Profile
Close

Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept

Graefe's Archive for Clinical and Experimental Ophthalmology Nov 08, 2019

Hara C, Wakabayashi T, Fukushima Y, et al. - Researchers undertook this retrospective, interventional, consecutive case series, to determine the features of patients who contracted tachyphylaxis on repeated intravitreal aflibercept (IVA) injections for neovascular age-related macular degeneration (AMD) as well as the frequency of tachyphylaxis. This study included 313 eyes (313 patients) with treatment-naïve AMD with resolution attained soon following the initiation of IVA and observed for ≥ 12 months. They examined the eyes for tachyphylaxis to aflibercept. Findings revealed that a minority of patients with AMD developed tachyphylaxis after repeated IVA injections for the long term, and the possibility of its occurrence was more in eyes with lesions beneath the retinal pigment epithelium and no intraretinal edema. Treatment of AMD should be conducted considering this fact while taking into account the consecutive treatment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay